Breaking News
Trump Evacuated As Shots Fired at White House Correspondents' Dinner, Shooter Dead
When the Cost of Truth Is High, We--and AI--Lie
Vanishing Minds: UFO & Nuclear Scientists Are Dying or Disappearing
The Great Iran Lie and the Persian Gulf Catastrophe
Top Tech News
Researchers Turn Car Battery Acid and Plastic Waste into Clean Hydrogen and New Plastic
'Spin-flip' system pushes solar cell energy conversion efficiency past 100%
A Startup Has Been Quietly Pitching Cloned Human Bodies to Transfer Your Brain Into
DEYE 215kWh LiFePO4 + 125,000W Inverter + 200,000W MPPT = Run A Factory Offgrid!!
China's Unitree Unveils Robot With "Human-Like Physique" That Can Outrun Most People
This $200 Black Shaft Air Conditions Your Home For Free Forever -- Why Is It Banned in the U.S.?
Engineers have developed a material capable of self-repairing more than 1,000 times,...
They bypassed the eye entirely.
The Most Dangerous Race on Earth Isn't Nuclear - It's Quantum.
This Plasma Stove Cooks Hotter Than The Sun 
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.